The use of natalizumab for multiple sclerosis
Rachel Brandstadter, Ilana Katz Sand Department of Neurology, Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Icahn School of Medicine at Mount Sinai, New York, NY, USA Abstract: Natalizumab is a monoclonal antibody that acts as an α4 integrin antagonist to prevent leukocyte t...
Main Authors: | Brandstadter R, Katz Sand I |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-06-01
|
Series: | Neuropsychiatric Disease and Treatment |
Subjects: | |
Online Access: | https://www.dovepress.com/the-use-of-natalizumab-for-multiple-sclerosis-peer-reviewed-article-NDT |
Similar Items
-
Anxiety and Perception of Disease Control in Multiple Sclerosis Subjects Treated with Natalizumab
by: Francesco Corallo, et al.
Published: (2023-12-01) -
Divergent Trends of Anti-JCPyV Serum Reactivity and Neutralizing Activity in Multiple Sclerosis (MS) Patients during Treatment with Natalizumab
by: Roberta Antonia Diotti, et al.
Published: (2016-05-01) -
Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: risk reduction, management and possibilities for subsequent immunoregulation
by: Natalia V. Khachanova, et al.
Published: (2019-12-01) -
Real-World Effectiveness of Natalizumab in Korean Patients With Multiple Sclerosis
by: Ki Hoon Kim, et al.
Published: (2021-07-01) -
Serological profile of John Cunningham virus (JCV) in patients with multiple sclerosis
by: Luciana Prats Branco, et al.